clindamycin and Allodynia

clindamycin has been researched along with Allodynia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alves, MS; Amaral, FA; Barbosa, BCM; Braga, AD; Braga, AV; Carneiro, FS; Carvalho, AFS; Coelho, MM; Costa, SOAM; da Costa, YFG; Lino, CI; Machado, RR; Melo, ISF; Morais, MI; Moreira, NF; Oliveira, RB; Oliveira, VLS; Queiroz-Junior, CM; Rodrigues, FF; Sousa, LP; Zaidan, I	1

Other Studies

1 other study(ies) available for clindamycin and Allodynia

Article	Year
A clindamycin acetylated derivative with reduced antibacterial activity inhibits articular hyperalgesia and edema by attenuating neutrophil recruitment, NF-κB activation and tumor necrosis factor-α production. International immunopharmacology, 2023, Volume: 122 Topics: Animals; Anti-Bacterial Agents; Arthritis; Clindamycin; Edema; Hyperalgesia; Inflammation; Lipopolysaccharides; Mice; Neutrophil Infiltration; NF-kappa B; Tumor Necrosis Factor-alpha; Zymosan	2023

Article

Year

A clindamycin acetylated derivative with reduced antibacterial activity inhibits articular hyperalgesia and edema by attenuating neutrophil recruitment, NF-κB activation and tumor necrosis factor-α production.

International immunopharmacology, 2023, Volume: 122

Topics: Animals; Anti-Bacterial Agents; Arthritis; Clindamycin; Edema; Hyperalgesia; Inflammation; Lipopolysaccharides; Mice; Neutrophil Infiltration; NF-kappa B; Tumor Necrosis Factor-alpha; Zymosan

2023